Nifty
:
17853.20
Sensex
:
60048.47
30.25 (0.17%)
163.11 (0.27%)
Nifty
Sensex
:
:
17853.20
60048.47
30.25 (0.17%)
163.11 (0.27%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :
49/99

BSE: 524500 | NSE: KILITCH

NSE BSE
167.60
24-Sep-2021
  • Open
  • High
  • Low
  • Previous Close
  •  171.95
  •  174.90
  •  166.50
  •  170.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  12655
  •  21.54
  •  228.90
  •  79.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 265.72
  • 42.90
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 275.53
  • N/A
  • 2.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.33%
  • 0.58%
  • 27.41%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.60
  • 20.50
  • 1.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -25.47
  • -70.26
  • -26.83

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.36
  • -
  • -45.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.39
  • 46.71
  • 56.53

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.01
  • 1.41
  • 1.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.41
  • 1.86
  • 29.33

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
19.63
10.19
92.64%
19.93
11.62
71.51%
20.33
15.93
27.62%
18.07
15.33
17.87%
Expenses
18.72
11.30
65.66%
19.60
13.93
40.70%
17.31
14.41
20.12%
15.12
13.62
11.01%
EBITDA
0.90
-1.11
-
0.33
-2.30
-
3.02
1.52
98.68%
2.96
1.71
73.10%
EBIDTM
4.60%
-10.92%
1.65%
-19.83%
14.85%
9.55%
16.36%
11.16%
Other Income
1.05
0.37
183.78%
1.51
1.47
2.72%
0.37
0.69
-46.38%
0.42
0.59
-28.81%
Interest
0.13
0.29
-55.17%
0.16
0.23
-30.43%
0.12
0.17
-29.41%
0.18
0.16
12.50%
Depreciation
0.44
0.49
-10.20%
0.50
0.52
-3.85%
0.50
0.59
-15.25%
0.50
0.45
11.11%
PBT
1.39
-1.52
-
1.17
-1.59
-
2.76
1.45
90.34%
2.71
1.68
61.31%
Tax
0.67
-0.19
-
0.46
-0.34
-
0.58
0.51
13.73%
0.50
0.35
42.86%
PAT
0.72
-1.33
-
0.71
-1.25
-
2.18
0.95
129.47%
2.21
1.34
64.93%
PATM
3.67%
-13.08%
3.55%
-10.72%
10.74%
5.94%
12.22%
8.72%
EPS
0.76
-0.86
-
0.46
-0.81
-
1.43
0.61
134.43%
1.35
0.87
55.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Net Sales
77.96
53.32
82.49
51.01
28.65
20.99
19.03
107.96
146.30
142.66
Net Sales Growth
46.90%
-35.36%
61.71%
78.05%
36.49%
10.30%
-82.37%
-26.21%
2.55%
 
Cost Of Goods Sold
41.08
29.09
48.17
26.00
11.25
8.73
7.02
71.19
100.27
98.28
Gross Profit
36.88
24.23
34.32
25.01
17.39
12.25
12.01
36.78
46.03
44.38
GP Margin
47.31%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
34.07%
31.46%
31.11%
Total Expenditure
70.75
53.33
76.47
45.71
29.20
25.29
20.79
95.34
124.23
118.99
Power & Fuel Cost
-
1.68
1.48
1.15
1.10
0.97
0.82
6.35
6.56
4.82
% Of Sales
-
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
5.88%
4.48%
3.38%
Employee Cost
-
5.69
5.28
4.30
3.38
3.47
3.13
6.44
5.62
4.10
% Of Sales
-
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
5.97%
3.84%
2.87%
Manufacturing Exp.
-
3.55
2.88
2.18
2.73
2.68
1.66
5.98
7.60
7.38
% Of Sales
-
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
5.54%
5.19%
5.17%
General & Admin Exp.
-
6.32
4.78
3.27
2.80
2.71
2.52
2.04
1.88
1.92
% Of Sales
-
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
1.89%
1.29%
1.35%
Selling & Distn. Exp.
-
6.20
8.64
5.22
4.71
3.46
2.00
2.02
1.47
1.57
% Of Sales
-
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
1.87%
1.00%
1.10%
Miscellaneous Exp.
-
0.80
5.24
3.59
3.21
3.27
3.64
1.32
0.83
0.92
% Of Sales
-
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
1.22%
0.57%
0.64%
EBITDA
7.21
-0.01
6.02
5.30
-0.55
-4.30
-1.76
12.62
22.07
23.67
EBITDA Margin
9.25%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
11.69%
15.09%
16.59%
Other Income
3.35
4.55
5.26
3.27
1.14
2.78
2.72
1.06
0.17
0.48
Interest
0.59
0.94
0.65
0.42
0.16
0.06
0.05
2.96
3.54
4.53
Depreciation
1.94
2.00
2.05
2.04
9.76
10.05
1.85
4.87
5.59
6.07
PBT
8.03
1.61
8.59
6.11
-9.32
-11.63
-0.95
5.84
13.12
13.55
Tax
2.21
0.77
4.76
0.96
-0.43
-0.44
-0.66
21.05
2.63
2.81
Tax Rate
27.52%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
21.62%
20.05%
20.74%
PAT
5.82
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.87
10.56
10.74
PAT before Minority Interest
6.19
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.31
10.49
10.74
Minority Interest
0.37
0.00
0.00
0.00
0.00
0.00
0.00
0.56
0.07
0.00
PAT Margin
7.47%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
71.20%
7.22%
7.53%
PAT Growth
2,106.90%
-78.07%
-25.63%
-
-
-
-
627.94%
-1.68%
 
EPS
3.73
0.54
2.46
3.30
-5.70
-7.17
-0.19
49.28
6.77
6.88

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Shareholder's Funds
118.25
121.06
112.03
101.20
108.69
119.88
114.55
84.31
75.15
Share Capital
15.43
15.36
13.73
13.23
13.23
13.23
13.23
13.23
13.20
Total Reserves
101.63
104.58
94.56
86.59
94.08
105.27
99.94
69.20
59.88
Non-Current Liabilities
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
0.82
0.89
38.48
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
42.99
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
Long Term Provisions
0.39
0.41
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
21.97
20.09
14.92
11.69
7.99
6.85
60.47
66.23
21.18
Trade Payables
7.10
4.35
7.72
5.68
3.69
2.39
3.66
10.25
11.83
Other Current Liabilities
1.22
3.89
3.50
3.22
3.35
3.92
1.33
38.00
2.16
Short Term Borrowings
12.61
9.45
0.92
0.69
0.19
0.00
8.77
15.63
0.00
Short Term Provisions
1.04
2.40
2.78
2.11
0.77
0.55
46.71
2.35
7.19
Total Liabilities
141.86
142.63
126.13
110.42
115.73
126.22
176.92
153.00
134.81
Net Block
31.53
32.13
32.96
33.31
42.41
9.38
8.64
41.93
44.26
Gross Block
70.59
69.19
67.97
66.28
65.62
22.55
20.78
74.27
70.99
Accumulated Depreciation
39.06
37.06
35.01
32.97
23.21
13.16
12.14
32.34
26.73
Non Current Assets
86.08
77.75
63.14
61.85
68.43
79.48
9.61
85.48
67.38
Capital Work in Progress
29.60
20.25
3.18
0.66
0.00
0.00
0.00
43.15
22.11
Non Current Investment
24.05
25.02
26.00
27.01
25.82
47.16
0.72
0.22
1.02
Long Term Loans & Adv.
0.36
0.34
0.22
0.08
0.20
22.94
0.25
0.19
0.00
Other Non Current Assets
0.54
0.00
0.79
0.79
0.00
0.00
0.00
0.00
0.00
Current Assets
55.79
64.88
62.98
48.57
47.27
46.72
167.31
67.51
67.08
Current Investments
27.81
28.42
30.29
26.02
23.12
24.67
137.59
0.00
0.00
Inventories
5.56
4.72
2.80
2.60
2.62
2.38
2.30
17.02
12.45
Sundry Debtors
15.86
19.44
20.69
14.61
16.37
12.62
15.03
38.70
47.92
Cash & Bank
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95
Other Current Assets
3.77
0.16
0.36
0.07
2.41
2.07
0.73
2.30
2.76
Short Term Loans & Adv.
3.73
4.21
4.07
2.98
2.38
2.00
0.22
1.30
2.71
Net Current Assets
33.81
44.78
48.07
36.87
39.28
39.87
106.84
1.28
45.90
Total Assets
141.87
142.63
126.12
110.42
115.73
126.23
176.92
152.99
134.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
3.75
0.29
1.42
1.12
17.23
-7.62
-29.35
22.08
12.04
PBT
1.61
8.59
6.11
-9.32
-11.63
-0.95
-9.69
13.12
13.55
Adjustment
-1.94
1.87
2.03
11.49
9.17
2.08
7.15
9.14
6.69
Changes in Working Capital
6.33
-5.99
-6.70
-1.08
19.71
-8.70
-26.81
-0.17
-5.01
Cash after chg. in Working capital
6.00
4.47
1.44
1.09
17.25
-7.56
-29.35
22.08
15.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
0.00
0.00
-3.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
41.02
-23.87
-20.42
Net Fixed Assets
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
96.84
-24.29
Net Investments
1.58
0.88
-4.21
-4.10
-20.40
68.35
-138.00
-0.71
Others
-11.03
-13.19
0.63
3.23
1.39
-97.55
82.18
1.13
Cash from Financing Activity
1.57
16.86
5.51
-0.04
0.11
-0.06
-9.49
7.33
7.31
Net Cash Inflow / Outflow
-5.14
3.17
2.48
-0.45
-2.23
-38.87
2.18
5.54
-1.07
Opening Cash & Equivalents
7.94
4.77
2.29
2.75
4.98
43.85
9.49
3.95
5.03
Closing Cash & Equivalent
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
75.85
78.11
78.86
75.44
81.07
89.54
85.53
62.30
55.09
ROA
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
46.26%
7.29%
7.96%
ROE
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
78.03%
13.52%
14.76%
ROCE
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
76.95%
13.06%
15.35%
Fixed Asset Turnover
0.76
1.20
0.76
0.44
0.48
0.88
2.33
2.05
2.01
Receivable days
120.72
88.79
125.86
197.00
252.10
265.25
88.74
106.38
122.60
Inventory Days
35.14
16.62
19.22
33.17
43.50
44.88
31.91
36.20
31.85
Payable days
42.27
32.14
59.43
52.58
37.09
69.84
26.25
31.47
35.31
Cash Conversion Cycle
113.59
73.27
85.65
177.59
258.51
240.30
94.40
111.12
119.14
Total Debt/Equity
0.11
0.08
0.01
0.01
0.00
0.00
0.08
0.64
0.59
Interest Cover
2.71
14.25
15.68
-58.98
-183.29
-17.71
33.88
4.71
3.99

Top Investors:

dipak kanayalal shah
iepf
llp

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant
    26th Jul 2021, 13:43 PM

    In early 2021 the company has started production of Antiseptic and Disinfectant products to help Ethiopia fight against the COVID-19 pandemic

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.